ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia

Autor: Currow, D. *, Temel, J.S., Abernethy, A., Milanowski, J., Friend, J., Fearon, K.C.
Zdroj: In Annals of Oncology August 2017 28(8):1949-1956
Databáze: ScienceDirect